健之佳20240429

Summary of the Conference Call Company and Industry Involved - The conference call pertains to Jianzhijia, a company in the pharmaceutical sector, discussing its 2023 annual report and the first quarter of 2024 [1] Core Points and Arguments - The call was hosted by the pharmaceutical analyst He Zhiying from Zhongxin Jian Investment, with participation from the company's board secretary, Mr. Li, and analysts from various brokerage firms including Xinda, Kaiyuan, and Dongwu [1] Other Important but Possibly Overlooked Content - The presence of multiple analysts from different brokerage firms indicates a broad interest in Jianzhijia's performance and future outlook, suggesting potential investor confidence in the company [1]